In the end, institutions almost always make the big money and control 80% or more of the shares of all great biotech stocks. That will likely happen here too. I see little chance of retailers selling on dips now. Instead, I see the opposite-- a potentially huge rise quickly into the $2's or $3's, with retailers panic-selling in order to lock in 100-300% gains (or more), with institutions gobbling up those shares. There's the shakeout.
Bio-- you may be right, but there will always be a financial reward for revolutionary medicine that's first in class. Especially for big diseases. But companies with new drugs that are only a bit better than standard of care won't be rewarded big like before-- Kerx and probably Sgyp fits into this category.
Smart move. FINALLY --a topical minocycline that's effective for acne for millions of teenagers. Worth $$billions. Slam dunk FDA approval if phase 3 is as good as expected.
Good idea, Help... AVXL is about to go bonkers, very soon. Fomx is a longer term play. When/if you pull some off the table with Avxl, then put it in Fomx.
Big BB holding, great price now. Amongst the best bet in biotech, after IDRA and AVXL. Just my opinion, fwiw.
(Btw, I don't have any spare cash and thus do not own it yet, so I did not recently buy and now pump)
Fwiw, if I had extra cash now (which I don't), I'd put my extra dollars int FOMX. A VERY good bet for a 5-10 bagger or buyout.
Carnage everywhere. Major shakeout/washout by the MM's
Adxs, Syn, Cur, Arna, Cldx, Hznp, Trov, Gale, Cytr, Snta, Ziop, Fomx, Ino, Arry, etc lol..
IDRA is actually holding up relatively well, folks. Keep the faith!
Sabby is the most well-known. However, there has been massive accumulation recently (I'm sure some is institutional), but we won't likely find out any info until AVXL's annual report. Institutions are not required to report OTC stock purchases/ holdings. When AVXL uplists to the Nasdaq, then we'll get full quarterly disclosure.
Yep, great biotech buys everywhere. Sgen, Trov, Cldx, Cur, you name it. Still nothing better than IDRA (or AVXL. Of the two, IDRA is definitely a safer bet, but the risk/reward quotient of AVXL at its current price is astronomical).
I agree, jrdelane... Fwiw, I've studied and have been in and out of a lot of biotechs over the years, and now have settled on only 2 biotech holdings, AVXL and IDRA. There are some great values out there now (Cldx and Trov, for example), but nothing compels me to sell any AVXL or IDRA to buy anything else at this time.
Hey Bio-- good luck with the timing there and trying to outsmart the market. Bubbles can go on much longer than anyone expects. The 90's tech bubble went on for years.
..since the announcement about IMO-2125. Who would have thought a year ago that IMO-2125 might in fact be our most important drug??
Obviously, shorts are covering some too...
I have the dubious distinction of buying some shares at the exact high of $6.87 (I think) when it ran up big 2 yrs ago. But I redeemed myself and picked up more shares near the exact low of $1.90 after the big fall!!!
I don't trust Iran at all. They still want to "wipe Israel off the map", in their own words. You can't negotiate with such people. On the other hand, we MUST negotiate with Putin. Trump is right, Fiorina is wrong on this. You've got to talk face to face with him and look him directly in the eye.